{
    "code": 0,
    "data": [
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached IP on Q3 and Nine Months FY26 Results",
            "news_id": "f67e00d7-1ed8-4083-aed6-c00367777246",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=864c812f-bdb9-4ed3-b185-3eb8c54bea52.pdf",
            "news_date": "2026-02-10 15:28:13",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q3 And Nine Months FY26 Results",
            "news_body": "Please find attached the Q3 and Nine Months FY26 Results",
            "news_id": "eb61d82e-67b1-4ff5-b8fd-d0aca0ecc13e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff316e1f-1028-4c2c-9fa5-1ef87f54e456.pdf",
            "news_date": "2026-02-10 14:21:00",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Investor Presentation Q2 FY 26 Financial Results",
            "news_id": "b101a2ac-f360-4a1f-8594-abb6b49a6203",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa06ebc2-ccb2-4517-b132-573e056b37d5.pdf",
            "news_date": "2025-11-14 15:38:39",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q2 FY26 Financial Results",
            "news_body": "Q2 FY26 Financial Results along with Limited Review Report thereon",
            "news_id": "1bb4294c-1c04-4e7d-bb6a-48967de9b399",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b392093-3acd-4967-b723-db96bd21633f.pdf",
            "news_date": "2025-11-14 15:21:38",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the Investor Presentation Q1 FY 26",
            "news_id": "e48ac15f-8ac8-413d-832e-a4d87d36e6d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28584864-96e0-424a-9bed-30e2567dafb5.pdf",
            "news_date": "2025-08-06 15:19:11",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q1-FY 26 Unaudited Financial Results",
            "news_body": "Please find attached the Q1-FY 26 Unaudited Financial Results",
            "news_id": "7900d73d-6a22-4403-a334-ce6392466538",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74e4f78c-8936-454e-8eaf-e6b0c7d3b794.pdf",
            "news_date": "2025-08-06 14:47:02",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Transcript of Analyst/Investors Conference Call- Q4 FY 25",
            "news_id": "37c9f165-5501-4fce-b598-41e045ba8cb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=091c81e5-c3d4-4227-ba31-ef8174c9edf7.pdf",
            "news_date": "2025-05-17 18:25:25",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed weblink of audio recording of Investor conference call on Q4 FY 25.",
            "news_id": "476c600e-8898-4da7-8bc7-989c1ac7dffc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f8a18f-8af6-4134-94da-09f0210c762f.pdf",
            "news_date": "2025-05-13 16:13:29",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Q4 & FY 25",
            "news_body": "Please find attached file.",
            "news_id": "b14901ca-c211-4a45-832f-d8a34bc1ed4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08bba81a-844d-459f-9cef-ed6a33e19388.pdf",
            "news_date": "2025-05-12 21:16:55",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation-Q4 FY25",
            "news_id": "86d06127-b4ff-4d2a-a2b5-90f61a86afcd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=961724a7-2500-4c97-b155-319614b29186.pdf",
            "news_date": "2025-05-12 16:41:36",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Consolidated And Standalone) For The Quarter / Year Ended March 31 2025",
            "news_body": "Please find attached the File",
            "news_id": "71cb0bde-a86e-45d2-b821-e0fdca67bc1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c3213f4-d2a0-42d3-8f28-4b8df2e9debf.pdf",
            "news_date": "2025-05-12 16:05:37",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached the transcript of analyst/investors conference call held on Thursday 06th February 2025 at 3:30 p.m.",
            "news_id": "b0929086-48c8-4490-b536-d0193e72a87f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6edf72a9-ffae-4c04-bea0-d399817dd932.pdf",
            "news_date": "2025-02-12 13:29:01",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor Presentation",
            "news_id": "0e8594c1-a5dd-442b-a7bf-471e8940e4f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67611ed7-e6ed-4fd2-9d1a-887b3ac76828.pdf",
            "news_date": "2025-02-06 14:18:41",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Results - Q3 FY 25",
            "news_body": "Please find attached the file",
            "news_id": "2ff99a50-3f8f-4bef-8d42-9102c156a5b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30af4f1b-2311-414b-be5a-1fdd1bd6a736.pdf",
            "news_date": "2025-02-06 14:11:17",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclsoed audio recording link of Analyst/ Investors Conference Call held today.",
            "news_id": "e7d7b304-684f-4ce1-a9a2-eb318df8d1d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5658d41-3eaa-4e91-8c7a-54e1ae7f609c.pdf",
            "news_date": "2024-11-12 17:27:56",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached investor presentation.",
            "news_id": "77e9a37f-79a6-4d3d-af50-f91e48642fb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49342495-83ce-40dc-ae69-19b51d52eaec.pdf",
            "news_date": "2024-11-11 14:31:25",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Q2 FY 25",
            "news_body": "Please find attached file.",
            "news_id": "691cfb78-613e-453f-9703-541dd020dcc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8f1c176-8ff2-44ef-8be7-c3be6c3484a1.pdf",
            "news_date": "2024-11-11 14:28:27",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Transcript of Earnings Conference Call Q1 FY 25",
            "news_id": "d6f7c396-0d1f-48a9-8b49-24723efef4b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c0661eb-cf59-46c5-b00a-c83caeb5bcf9.pdf",
            "news_date": "2024-08-17 11:40:55",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed weblink of the audio recording of analyst/ investors'' conference call held on 14th August 2024.",
            "news_id": "80cf0899-f024-4357-8c96-910cbb901b7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cae3be8c-2806-4279-bc7f-ed3501796c5e.pdf",
            "news_date": "2024-08-14 16:06:59",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed investors presentation - Q1 FY25 results.",
            "news_id": "c55bf72d-23c6-45d3-a0b2-40f58d633159",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19da10fa-b727-4456-afd6-3d227a398150.pdf",
            "news_date": "2024-08-12 10:13:41",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Q 1 FY 2025",
            "news_body": "Please find enclsoed results for the Q1 FY 25.",
            "news_id": "f25c4c9f-1a88-49a2-b7dc-d97e69fe9331",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76a56ee0-24d0-4ecf-bfbd-973f9880c9f2.pdf",
            "news_date": "2024-08-12 10:04:04",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed transcript of earnings conference call held on Wednesday, 22nd May 2024.",
            "news_id": "89a06ad7-0d43-4bc2-9b4f-9d3f8e6247ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22260977-a0bb-4b84-8715-00f8aaf4a29e.pdf",
            "news_date": "2024-05-28 19:10:06",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached letter comprising weblink of audio recording of Analyst/ Investors Conference Call held today i.e., 22-May-2024.",
            "news_id": "27c5547c-a1c9-4321-940b-03b2755848ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c50b08b-d6ce-4d21-8cdc-c587e320ea5e.pdf",
            "news_date": "2024-05-22 17:57:10",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed revised investors presentation.",
            "news_id": "f47a2efe-3e77-4642-adc0-84246fd9a4e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b75fa46c-a25d-42d9-8b31-1625a18c80ea.pdf",
            "news_date": "2024-05-22 12:09:28",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Q4 FY 2024",
            "news_body": "Please find enclosed file",
            "news_id": "56d7b888-2525-4a89-975d-7fb0f1560ce6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d12639da-2549-4769-89ae-44ae59a99bb1.pdf",
            "news_date": "2024-05-21 19:05:18",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed Investors Presentation on audited financial results for the quarter and financial year ended Q4 FY 2024.",
            "news_id": "25954adc-85f6-4371-a166-4bd861bf496a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2618db98-6b2a-4ac9-b093-d39f7328c31a.pdf",
            "news_date": "2024-05-21 16:18:03",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached transcript of earnings conference call held on 1-Feb.-2024 at 12.00 Noon (IST).",
            "news_id": "e9c53206-10df-4792-8677-8249bdbd41b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f16d25ac-c340-497e-9d7c-50b246f11958.pdf",
            "news_date": "2024-02-03 15:56:58",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached letter comprising weblink of audio recording of Earnings Conference Call held on 1st February 2024 on unaudited consolidated and standalone financial results for Q-3 FY 2024 of the company .",
            "news_id": "73f62c82-d48f-4942-b83d-3383a036c1da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3764ce38-effc-477c-ab52-fec5e47369fb.pdf",
            "news_date": "2024-02-01 19:11:32",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Earnings Presentation Q3 FY 24 - January 24.",
            "news_id": "7f70c31a-1a03-4de6-8fd2-f9a3d76bcb03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8329e18-bf05-44ef-b2d5-d37d90a2bc2c.pdf",
            "news_date": "2024-01-31 14:58:39",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Q3 FY 2024",
            "news_body": "Please find enclosed Q-3 results along with LLR.",
            "news_id": "b6555347-0081-4d6e-b2a4-37ebbf3091b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a82fbde6-56e4-4557-bffb-bb8a90bccb3a.pdf",
            "news_date": "2024-01-31 14:22:22",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached transcript of earnings conference call held on 3rd November 2023 at 12.15 p.m.",
            "news_id": "6a7df124-e300-4db0-9559-c3b40fb9a089",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bfb9ace-9cc8-4a6c-89a2-8f83f8963aed.pdf",
            "news_date": "2023-11-08 16:18:13",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earning conference call held on 3rd November 2023.",
            "news_id": "1c20b001-2c40-4d53-bc06-0f0928951f1d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a18519b-30b5-42ff-a456-fc07e1e5dcc7.pdf",
            "news_date": "2023-11-03 20:37:53",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached (Q2-FY24) presentation.",
            "news_id": "081e5d03-5119-4dd5-b28d-9b04bb8dd8f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=457c19e8-a7d1-4137-a203-244a42c29d14.pdf",
            "news_date": "2023-11-02 15:25:08",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended On September 30, 2023.",
            "news_body": "Please find attached financial results for the quarter and half year ended on September 30, 2023 along-with limited review report thereon.",
            "news_id": "cec467d4-137a-45a8-b3eb-4a9a7f7e5d48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf560223-2b3d-4795-9728-d27feffbdb3b.pdf",
            "news_date": "2023-11-02 14:23:58",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors presentation (Q1'' FY24), on the financial performance of the company for the quarter ended on 30th June 2023.",
            "news_id": "29451000-ec9b-4917-b8cf-e52be2cc4123",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31781256-7254-459e-afa4-46665f5279c8.pdf",
            "news_date": "2023-08-08 11:15:51",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Financial Results For The Quarter Ended 30 June 2023",
            "news_body": "Unaudited financial results for the quarter ended 30th June 2023",
            "news_id": "aa34edd8-a50e-4029-9acb-a09cf46be2ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f5beec-8488-46f9-8f0d-fae41524e1a1.pdf",
            "news_date": "2023-08-05 14:26:29",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q4'FY23) May, 2023, based on the financial performance of the company for the quarter and financial year ended 31st March 2023.",
            "news_id": "bdb74b81-9dae-4d0d-a0c3-5e20d12f066a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78433655-f234-467d-bd9f-12c0f5ff67a8.pdf",
            "news_date": "2023-05-16 16:38:22",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended 31St March 2023",
            "news_body": "This is to inform you that the Board of Directors of the company, in their meeting held on Tuesday, 16th May 2023 (commenced at 11.30 A.M. and concluded at 04:15 P.M.), have, inter-alia, considered and approved audited standalone and consolidated financial results of the company for the quarter and financial year ended 31st March 2023, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <BR> <BR> A copy of the 'Results' along with the report of the auditors of the company, with unmodified opinion, thereon and a declaration to that effect, are enclosed herewith.",
            "news_id": "08951975-6ae7-4c18-8a03-321c100a69f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba092d40-9d09-4ffb-b61b-97731ae583be.pdf",
            "news_date": "2023-05-16 16:29:16",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation (Q3' FY23) February 2023",
            "news_id": "f5d898c5-2350-46cd-b362-31716510495c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cb28075-1825-4444-a454-64667372e312.pdf",
            "news_date": "2023-02-13 15:21:00",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "This is to inform you that the Board of Directors of the company, in their meeting held on Monday, 13th February 2023 (commenced at 11:00 A.M. and concluded at 01:40 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and nine months ended 31st December 2022, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the company for the quarter and nine months ended 31st December 2022, are enclosed herewith.",
            "news_id": "591585bb-44f4-44fa-97c7-e042f0699f22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f22cbc2-4618-47d3-abae-1129d60e0fb9.pdf",
            "news_date": "2023-02-13 13:58:31",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September 2022",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, in connection with declaration of unaudited standalone andconsolidated financial results for the quarter and half year ended 30th September 2022, please find enclosed disclosure of Related Party Transactions, for half year ended 30th September2022 (i.e., from 1st April 2022 to 30th September 2022).",
            "news_id": "4e448a40-e008-4d44-8f93-776041706091",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0c49494-0525-45ed-9ee2-cda68f49a787.pdf",
            "news_date": "2022-11-24 18:43:02",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q2' FY23) November 2022, based on the financial performance of the company for the quarter and half year ended 30th September 2022.",
            "news_id": "c89b39d3-dd09-4c8b-8f68-b98522f2de82",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=326f4699-df53-46a2-b0d5-1360422f11f7.pdf",
            "news_date": "2022-11-10 14:03:06",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "This is to inform you that the Board of Directors of the company, in their meeting held on Thursday, 10th November 2022 (commenced at 11:00 A.M. and concluded at 01:25 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2022, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR>",
            "news_id": "e9aebfdb-722a-434d-b59c-04ed98d43453",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=835af6f2-c7f1-4058-8050-f5e510c0873d.pdf",
            "news_date": "2022-11-10 13:51:19",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q1'FY23) July, 2022, based on the financial performance of the company for the quarter ended 30th June, 2022.",
            "news_id": "1255d0f2-d0cf-4ea3-9ff6-265539abf770",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc0b481a-8c51-4049-8e59-5323eb34219b.pdf",
            "news_date": "2022-07-29 14:06:22",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Morepen Laboratories Limited",
            "news_body": "Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that the Board of Directors of the company in their meeting held today i.e., Friday, 29th July, 2022 (commenced at 11:15 A.M. and concluded at 1.30 P.M.), have, inter-alia, considered and approved results and other items as enclosed.",
            "news_id": "26c18bd9-a1ac-44da-94e1-0f491ae94ae3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=741c1fee-0a95-46d0-bef5-40983db2ce88.pdf",
            "news_date": "2022-07-29 13:52:25",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Outcome of the meeting of the Board of Directors of Morepen Laboratories Limited",
            "news_id": "30ea4149-a926-4f4e-ae90-a98dce9924de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de4627d5-6ced-4330-9233-3c3fa6b74fc2.pdf",
            "news_date": "2022-07-29 13:47:43",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, in connection to declaration of audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2022 on 5th May, 2022, please find enclosed disclosure of Related Party Transactions, for half yearended 31st March, 2022 (i.e., from 1st October, 2021 to 31st March, 2022).",
            "news_id": "59392ce3-5531-4569-b0e6-b2c58c9b85e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a3309bd-c530-4fa2-a4d2-a75f2b8d60d6.pdf",
            "news_date": "2022-05-20 20:35:25",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended, we wish to inform you that the audio recordings of 'Analyst/ Investor Conference Call' held today, i.e., Friday, 6th May, 2022 at 4.00 P.M. (IST), on post declaration of results for quarter and financial year ended March 31, 2022, is available on the Company''s website.",
            "news_id": "6f26fa0e-e7bd-4a68-9a4e-57c46d36c503",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74a019eb-757d-4b0d-ab8b-2a03e7b4414d.pdf",
            "news_date": "2022-05-06 19:41:09",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q4'FY22) May, 2022, based on the financial performance of the Company for the quarter and financial year ended 31st March, 2022.",
            "news_id": "03f9ece7-cdc2-46be-b8af-e0f5affc8c45",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41b09155-7ed7-4a35-b276-d8c9c846028d.pdf",
            "news_date": "2022-05-05 13:57:59",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Q4 FY 2022",
            "news_body": "Results for the Q4 FY 2022",
            "news_id": "40fc15d4-730e-4323-b0d4-65631b455916",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=125d607f-60e3-4bcc-8d9f-e88d3bfbcd25.pdf",
            "news_date": "2022-05-05 13:32:04",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached transcript of 'Analyst/ Investor Conference Call' organised on Wednesday, 9th February 2022 at 04:00 P.M. (IST), subsequent to the declaration of unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December, 2021.",
            "news_id": "d734daca-9104-44d1-ac0f-7fc5697e3c38",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b112bef2-451c-401d-980b-137ee8765900.pdf",
            "news_date": "2022-02-12 21:45:23",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q3'FY22) February 2022, based on the financial performance of the Company for the Quarter and Nine months ended 31st December, 2021.",
            "news_id": "91f48257-893b-4dc2-a1c5-9b59a2a248ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2e87ed3-403b-463a-9186-dcb4d2cf14b2.pdf",
            "news_date": "2022-02-08 12:11:14",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter And Nine-Months Ended 31St December, 2021",
            "news_body": "Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that, the Board of Directors of the company in their meeting held today i.e., Tuesday, 8th February 2022 (commenced at 10.30 a.m. and concluded at 11:30 a.m.), inter-alia, considered and approved: - <BR> <BR> (1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine-months ended 31st December, 2021.<BR> <BR> (2) Variation/alteration of preference shareholders' rights by issue and allotment of 97,35,201, 0.01% Compulsorily Convertible Preference Shares ('CCPS') of Rs. 100/- each in lieu of existing 97,35,201, 0.01% Optionally Convertible Preference Shares ('OCPS') of Rs. 100/- each; and 17,30,000, 0.01% CCPS of Rs. 100/- each in lieu of existing 17,30,000, 0.01% Cumulative Redeemable Preference Shares ('CRPS') of Rs. 100/-.<BR>",
            "news_id": "5d4503d0-0a3f-456d-8647-e37c13b72f69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb7db00f-6e4b-42dc-b121-99fd51d2ca69.pdf",
            "news_date": "2022-02-08 11:59:11",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached transcript of 'Analyst/ Investor Conference Call' organised on Thursday, 11th November, 2021 at 04:00 P.M. (IST), subsequent to the declaration of unaudited standalone and consolidated financial results for the quarter and half year ended 30th September, 2021.",
            "news_id": "8cab04e4-b209-4a76-93ae-558e5b92e2af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ad4f77f-92e0-4ce1-9c5b-f5a6fe37ec0e.pdf",
            "news_date": "2021-11-18 18:00:43",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation (Q2' FY22) November, 2021",
            "news_id": "a4644616-c0bf-42f7-8012-19999f66990a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=375d5da7-f3e9-43f7-9a1a-dbadda124f7d.pdf",
            "news_date": "2021-11-11 14:03:19",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Quarter And Half Year Ended September 30, 2021",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Thursday, 11th November, 2021 (commenced at 11.00 A.M. and concluded at 01.30 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> <BR> A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter and half year ended 30th September, 2021 is enclosed herewith.<BR>",
            "news_id": "e81c94b1-2a40-4a0b-be7a-34929c8eb360",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05e3abfb-5ad8-4b84-9aa8-28b073d434b9.pdf",
            "news_date": "2021-11-11 13:57:25",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On November 11, 2021",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Thursday, 11th November, 2021 (commenced at 11.00 A.M. and concluded at 01.30 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.  <BR> <BR> A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter and half year ended 30th September, 2021 is enclosed herewith.",
            "news_id": "1d3bee35-8209-4985-87de-28c071a97ce0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7229a662-45f4-4d78-8043-f7a324bc36f1.pdf",
            "news_date": "2021-11-11 13:46:19",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached transcript of 'Analyst/ Investor Conference Call' organised on Tuesday, 27th July 2021 at 04.00 P.M. (IST) subsequent to declaration of unaudited standalone and consolidated financial results for the quarter ended 30th June 2021.",
            "news_id": "66740b01-1a7c-4781-bee4-df9937ede319",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5151e0e4-c573-4a3d-9113-e4993abe0296.pdf",
            "news_date": "2021-07-31 19:18:02",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q1'FY22) July, 2021, based on the financial performance of the Company for the quarter ended 30th June, 2021.",
            "news_id": "3bd0943f-408a-4a73-988e-e45fd99aec53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ff7dabd-0f72-474b-9df6-4810c406babc.pdf",
            "news_date": "2021-07-27 12:22:24",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30, 2021",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Tuesday, 27th July, 2021 (commenced at 09:30 AM and concluded at 11:30 AM), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <BR> <BR> A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter ended 30th June, 2021 is enclosed herewith.",
            "news_id": "94888781-d36e-4b30-8ddf-d560c56a1e6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1aa3d6b5-2324-40bc-8e12-b22ac0b67cfd.pdf",
            "news_date": "2021-07-27 11:53:33",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of Board Of Directors Of The Company Held On July 27, 2021",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Tuesday, 27th July, 2021 (commenced at 09:30 AM and concluded at 11:30 AM), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.<BR> <BR> A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter ended 30th June, 2021 is enclosed herewith.",
            "news_id": "4c22001b-013f-4934-af0a-4ba3c6139106",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea48bf26-9411-4d6c-b683-673c2340e97a.pdf",
            "news_date": "2021-07-27 11:42:32",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021, Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, in connection to declaration of audited<BR> Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021 on May 04, 2021, please find enclosed disclosure of Related Party<BR> Transactions on a consolidated basis, for half year ended March 31, 2021 (i.e., from October 01, 2020 to March 31, 2021).",
            "news_id": "67c8baa3-a139-4820-b5c4-25a41a1d10c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e03f11d4-2421-4df7-b164-a24c5b23aae4.pdf",
            "news_date": "2021-05-27 21:41:37",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of 'Analyst/ Investor Conference Call' on Results - Q4 & FY 2020-21",
            "news_id": "fd7cddf6-99a6-4068-96c4-fc7c46741e40",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19ef7db0-a5b1-488b-988b-77ee164e4898.pdf",
            "news_date": "2021-05-06 19:55:53",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation (Q4'FY21) May, 2021",
            "news_id": "a2e5fe97-1d1f-46d9-af63-9ed8908fa251",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d2f90ae-6f10-4944-9ec5-6fc146656846.pdf",
            "news_date": "2021-05-04 11:25:59",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Tuesday, 04th May, 2021 (commenced at 09:50 A.M. and concluded at 10:22 A.M.), have, inter-alia, considered and approved the audited standalone and consolidated financial results of the Company for the quarter and financial year ended 31st March, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <BR> <BR> A copy of the 'Results' along with the Report of the Auditors of the Company, with unmodified opinion, thereon and a declaration to that effect is enclosed herewith.<BR>",
            "news_id": "5587e0a5-9c37-4030-8dd5-1aed04b3127a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55219e2f-755d-4bdf-bc2c-af541a443785.pdf",
            "news_date": "2021-05-04 11:16:41",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation (Q3'FY21) February 2021, based on the financial performance of the Company for the Quarter and Nine months ended 31st December, 2020.<BR> <BR>",
            "news_id": "93880160-df91-4398-a00f-e996f269e423",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad7d7966-2961-4fdb-991d-af2a8d83b3a8.pdf",
            "news_date": "2021-02-12 15:17:40",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December, 2020",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Friday, 12th February, 2021 (commenced at 12.15 P.M. and concluded at 2.00 P.M.), have, inter-alia, considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine-months ended 31st December, 2020.<BR> <BR> Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, a copy of the 'Results' along-with Limited Review Report of the Statutory Auditors of the Company, are enclosed herewith.",
            "news_id": "7904495d-18dd-40aa-8da5-d5d43a0f432c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b04bbdb-77a6-42ff-aaba-499a155a7845.pdf",
            "news_date": "2021-02-12 14:28:35",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MOREPENLAB",
            "disp": "Morepen Laboratories",
            "bse_code": 500288,
            "isin": "INE083A01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "This is to inform you that the Board of Directors of the Company, in their meeting held on Friday, 12th February, 2021 (commenced at 12.15 P.M. and concluded at 2.00 P.M.), have, inter-alia, considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine-months ended 31st December, 2020.<BR> <BR> Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, a copy of the 'Results' along-with Limited Review Report of the Statutory Auditors of the Company, are enclosed herewith.<BR>",
            "news_id": "76e64069-4b39-498f-a093-7a61be0fc1a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=976384dd-9abf-4e24-9339-81815b3de73d.pdf",
            "news_date": "2021-02-12 14:25:56",
            "seo": "morepen-laboratories-ltd",
            "ltp": 39.7,
            "ch": -0.21999999999999886,
            "pch": -0.5511022044088149,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 2259,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}